First Wave BioPharma Inc.

NASDAQ: FWBI · Real-Time Price · USD
2.96
0.13 (4.59%)
At close: May 16, 2024, 10:00 PM

First Wave BioPharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
163.48K 3.71M 1.36M 8.25M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a 21.52K 21.51K n/a
Other Long-Term Assets
119.77K 11.25K 39.66K 44.01K
Receivables
n/a n/a 93.01K n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
83.32M 1.24M 1.96M 1,176.3B
Total Current Assets
83.48M 4.96M 3.41M 9.42M
Property-Plant & Equipment
126.75K 210K 303.1K 409.31K
Goodwill & Intangibles
1.68M 1.68M 1.68M 1.91M
Total Long-Term Assets
1.93M 1.93M 2.03M 2.37M
Total Assets
85.41M 6.88M 5.44M 11.79M
Account Payables
2.96M 554.28K 720.04K 2.68M
Deferred Revenue
n/a 1.07M n/a 884.43K
Short-Term Debt
81.51K 679.89K 669.64K 719.23K
Other Current Liabilities
24.51M 829.53K 1.09M 8.01M
Total Current Liabilities
27.55M 3.13M 2.48M 12.3M
Long-Term Debt
59.02K 146.95K 214.06K 311.14K
Other Long-Term Liabilities
n/a 0.00 0.00 7M
Total Long-Term Liabilities
59.02K 146.95K 214.06K 7.31M
Total Liabilities
27.61M 3.28M 2.7M 19.61M
Total Debt
140.53K 826.84K 883.71K 1.03M
Common Stock
475.00 156.00 100.00 1.49K
Retained Earnings
-202.39M -184.33M -168.53M -153.9M
Comprehensive Income
n/a 0.00 n/a -1.22M
Shareholders Equity
-3.88M 3.6M 2.74M -7.82M
Total Investments
n/a 21.52K 21.51K n/a